Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$26K Hold
1,092
﹤0.01% 3810
2019
Q3
$19K Hold
1,092
﹤0.01% 3985
2019
Q2
$16K Buy
1,092
+484
+80% +$8.65K ﹤0.01% 4095
2019
Q1
$12K Hold
608
﹤0.01% 4257
2018
Q4
$11K Buy
608
+372
+158% +$6.61K ﹤0.01% 4131
2018
Q3
$4K Buy
236
+10
+4% +$206 ﹤0.01% 4639
2018
Q2
$4K Sell
226
-3,003
-93% -$66K ﹤0.01% 4437
2018
Q1
$79K Sell
3,229
-4,230
-57% -$111K ﹤0.01% 2744
2017
Q4
$214K Buy
7,459
+3,474
+87% +$109K ﹤0.01% 1949
2017
Q3
$109K Buy
3,985
+2,350
+144% +$52K ﹤0.01% 2324
2017
Q2
$34K Buy
1,635
+1,568
+2,340% +$33.1K ﹤0.01% 3109
2017
Q1
$1K Hold
67
﹤0.01% 4489
2016
Q4
$1K Hold
67
﹤0.01% 4322
2016
Q3
$1K Hold
67
﹤0.01% 4267
2016
Q2
$0 Buy
+67
New +$719 ﹤0.01% 4379

Other funds holding ACLS

Advisor Group's ACLS Position: Q4 2019 in Review

Advisor Group held its Axcelis (ACLS) position steady in Q4 2019 at 1,092 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #3810.

Advisor Group first reported a position in ACLS in Q2 2016 and has held it in 15 quarters since. The position peaked at $214K in Q4 2017. 139 funds tracked by Wall St. Rank hold ACLS as of Q4 2019.

  • Advisor Group held 1,092 shares of Axcelis worth $26K as of Q4 2019.
  • Advisor Group left its Axcelis share count unchanged in Q4 2019.
  • Axcelis made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3810 holding.
  • Advisor Group first reported a position in Axcelis in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Axcelis position peaked at $214K in Q4 2017.
  • 139 funds tracked by Wall St. Rank held Axcelis as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.